Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes. 1995

M Holodniy, and L Mole, and B Yen-Lieberman, and D Margolis, and C Starkey, and R Carroll, and T Spahlinger, and J Todd, and J B Jackson
AIDS Research Center, Veterans Affairs Medical Center, Palo Alto, CA 94304, USA.

This study compared the levels of human immunodeficiency virus (HIV) virion RNA in plasma from whole blood collected in VACUTAINER CPT (cell preparation tube), VACUTAINER PPT (plasma preparation tube), VACUTAINER SST (serum separation tube), and standard VACUTAINER tubes with sodium heparin, acid citrate dextrose, sodium citrate, and potassium EDTA used as anticoagulants. Quantitative plasma HIV RNA levels were measured by branched-DNA signal amplification. Blood from all tubes was either processed within 1 to 3 h after collection or stored at room temperature or at 4 degrees C for analysis at 6 to 8 and 30 h postdraw. Immediately separated plasma from sodium citrate CPT tubes held at 4 degrees C maintained better stability of HIV RNA equivalents than whole blood held at room temperature or 4 degrees C. The highest number of HIV RNA equivalents was seen with EDTA VACUTAINER tubes. HIV RNA equivalents in all types of plasma were significantly higher than in SST tubes. Although a decline in HIV RNA equivalents was seen in all collection devices after 30 h, a significantly greater decline in plasma HIV RNA equivalents occurred in acid citrate dextrose VACUTAINER tubes than in citrate CPT, PPT, and standard EDTA VACUTAINER tubes. In order to minimize the variability of quantitative HIV RNA test results, our data suggest that samples collected for a particular assay should be processed at the same time postdraw using a particular tube type throughout a given study.

UI MeSH Term Description Entries
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D013696 Temperature The property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms. Temperatures
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014766 Viremia The presence of viruses in the blood. Viremias
D014773 Virology The study of the structure, growth, function, genetics, and reproduction of viruses, and VIRUS DISEASES.

Related Publications

M Holodniy, and L Mole, and B Yen-Lieberman, and D Margolis, and C Starkey, and R Carroll, and T Spahlinger, and J Todd, and J B Jackson
January 2000, Journal of clinical microbiology,
M Holodniy, and L Mole, and B Yen-Lieberman, and D Margolis, and C Starkey, and R Carroll, and T Spahlinger, and J Todd, and J B Jackson
August 2005, Journal of clinical microbiology,
M Holodniy, and L Mole, and B Yen-Lieberman, and D Margolis, and C Starkey, and R Carroll, and T Spahlinger, and J Todd, and J B Jackson
August 2023, Journal of immunological methods,
M Holodniy, and L Mole, and B Yen-Lieberman, and D Margolis, and C Starkey, and R Carroll, and T Spahlinger, and J Todd, and J B Jackson
February 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
M Holodniy, and L Mole, and B Yen-Lieberman, and D Margolis, and C Starkey, and R Carroll, and T Spahlinger, and J Todd, and J B Jackson
August 2018, Clinica chimica acta; international journal of clinical chemistry,
M Holodniy, and L Mole, and B Yen-Lieberman, and D Margolis, and C Starkey, and R Carroll, and T Spahlinger, and J Todd, and J B Jackson
January 2020, AIDS research and human retroviruses,
M Holodniy, and L Mole, and B Yen-Lieberman, and D Margolis, and C Starkey, and R Carroll, and T Spahlinger, and J Todd, and J B Jackson
January 2001, Journal of clinical microbiology,
M Holodniy, and L Mole, and B Yen-Lieberman, and D Margolis, and C Starkey, and R Carroll, and T Spahlinger, and J Todd, and J B Jackson
November 1997, Journal of clinical microbiology,
M Holodniy, and L Mole, and B Yen-Lieberman, and D Margolis, and C Starkey, and R Carroll, and T Spahlinger, and J Todd, and J B Jackson
November 1991, Clinical chemistry,
M Holodniy, and L Mole, and B Yen-Lieberman, and D Margolis, and C Starkey, and R Carroll, and T Spahlinger, and J Todd, and J B Jackson
November 2006, Annals of clinical biochemistry,
Copied contents to your clipboard!